Advertisement
Review

Review "Review articles synthesize in narrative form the best available evidence on a topic. Review articles are only published as part of Supplements to PLOS Medicine and are not featured in the PLOS Medicine Magazine.",

See all article types »

A Research Agenda for Malaria Eradication: Vaccines

  • The malERA Consultative Group on Vaccines mail

    cchitnis@icgeb.res.in

    Full listing of the members of the malERA Consultative Group on Vaccines can be found in the Acknowledgments.

    X
  • Published: January 25, 2011
  • DOI: 10.1371/journal.pmed.1000398
  • Featured in PLOS Collections

About the Author

Corresponding Author

Email: cchitnis@icgeb.res.in

Competing Interests

No competing interests: PLA, CC, VM, AS, DW. GB is the Chair of MALVAC, Chair of the USAID Malaria Vaccine Development Program Scientific Consultants Group, a member of the Board of Roll Back Malaria, and the APMEN Advisory Board. RB is an employee of Glaxo SmithKline (GSK) and owns GSK stock. GSK is developing malaria vaccines. At the time of the malERA meetings, RB was employed by the Bill & Melinda Gates Foundation. CL states that the PATH Malaria Vaccine Initiative has partnerships with several commercial entities developing malaria vaccines. Each partnership has defined access conditions.

Author Contributions

CC is the corresponding author on behalf of the malERA Consultative Group on Vaccines. Chaired the group: CC. ICMJE criteria for authorship read and met: PLA, RB, GB, DW, CC, CL, VM, AS. Participated in one or more discussion meetings resulting in the writing of this article: The malERA Consultative Group on Vaccines.